Cities, counties and other local governments may apply through April 20 for grants to work with community-based organizations to encourage COVID-19 safety and vaccination in vulnerable and underserved populations.

The $250 million initiative — Advancing Health Literacy to Enhance Equitable Community Responses to COVID-19 — expects to fund about 30 urban and 43 rural communities for two years. Recipients will develop and implement a plan to better reach racial, ethnic and other vulnerable populations with COVID-19 public health information and services.

"Information is power, especially the ability to understand and use information to support better health,” said Acting Assistant Secretary for Health Rear Admiral Felicia Collins, M.D. “Whether it helps us understand where to get tested or the benefits of the COVID-19 vaccine, information is a crucial part of keeping families and communities safe. Nowhere is this more important than in communities hit hardest by the pandemic, especially racial and ethnic minority communities and other vulnerable populations."

Headline
Joy A. Rhoden, AHA senior vice president and executive director of health outcomes and care transformation, explores the economic impact of health disparities…
Blog
Public
Hospital and health system leaders are navigating workforce shortages, reimbursement pressures, caring for a sicker patient population and rising operational…
Headline
The Department of Health of Human Services Aug. 21 issued a request for information seeking feedback on immunization categories within the Aug. 10 executive…
Headline
For the 2025-2026 school year, exemptions from one or more vaccines among U.S. kindergartners was at 4.2%, increasing from 3.6% for the previous school year,…
Headline
The AHA Aug. 11 released a new resource guide designed to address a critical gap by helping leaders understand and quantify the economic burden of…
Headline
A study published Aug. 5 by Nature found that COVID-19 infection can reactivate dormant, chronic viruses such as Epstein-Barr and cytomegalovirus. The study…